Acta Pharmacol Sin (2012) 33(1):7581
While the appetite suppressive effects of amylin and GLP-1 receptor agonists are known to involve direct actions in the brain 6,7,9,10,12,13,14 , uncovering the neuroanatomical site(s) of action and the physiological mechanisms that mediate the anorectic response remains an area of intense research focus
Denying individuals access to these medications may perpetuate feelings of shame and failure, particularly when traditional methods have proven ineffective
11 Challenges and future directions in targeting CUL5 for tumor cell therapy 11.1 Limitations and advances in existing pharmacological intervention strategies Currently, few drugs directly target CUL5
And this is the point of this, this is educational, right
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development